1. Antidiabetic drugs use and new-onset atrial fibrillation in patients with diabetes mellitus. (14th October 2021) Authors: Fauchier, L; Fauchier, G; Bisson, A; Bodin, A; Herbert, J; Angoulvant, D; Ducluzeau, P.H; Lip, G.Y.H Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bleeding risks with frailty and multimorbidity in patients with atrial fibrillation. A nationwide analysis of 1.4 million subjects. (25th November 2020) Authors: Fauchier, L; Bisson, A; Bodin, A; Herbert, J; Clementy, N; Pierre, B; Angoulvant, D; Hanon, O; Babuty, D; Lip, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiovascular events in metabolically healthy obese. A nationwide cohort study. (14th October 2021) Authors: Fauchier, G; Bisson, A; Semaan, C; Herbert, J; Bodin, A; Angoulvant, D; Ducluzeau, P H; Lip, G Y H; Fauchier, L Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical outcomes and death associated with cardiorenal syndromes. A comprehensive nationwide cohort study. (14th October 2021) Authors: Fauchier, L; Gatault, P; Bisson, A; Gueguen, J; Gouin, N; Sautenet, B; Herbert, J; Angoulvant, D; Halimi, J M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of cardiorenal syndrome and its different subtypes on incidence of atrial fibrillation in a nationwide analysis. (19th May 2022) Authors: Fauchier, L; Bisson, A; Maisons, V; Bodin, A; Herbert, JM; Angoulvant, D; Halimi, JM; Lip, GYH Journal: Europace Issue: Volume 24:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immuno-inflammatory response in patients after myocardial infarction and involvement in fibrosis in vitro. (3rd October 2022) Authors: Miquelestorena-Standley, E; Vinhais Da Silva, A V; Monnier, M; Chadet, S; Lemoine, R; Ivanes, F; Angoulvant, D Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of the timing of coronary revascularization relative to the transcatheter aortic valve implantation procedure: insights from a propensity score analysis based on a nationwide analysis. (25th November 2020) Authors: Lantelme, P; Bisson, A; Lacour, T; Herbert, J; Ivanes, F; Bourguignon, T; Quilliet, L; Angoulvant, D; Harbaoui, B; Bonnet, M; Bernard, A; Babuty, D; Saint-Etienne, C; Deharo, P; Fauchier, L Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of type 2 diabetes on the incidence of cardiorenal syndromes and on subsequent clinical outcomes: a propensity-matched nationwide analysis. (3rd October 2022) Authors: Fauchier, L; Maisons, V; Fauchier, G; Herbert, J; Angoulvant, D; Ducluzeau, P H; Halimi, J M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Incidence of atrial fibrillation in patients with diabetes mellitus: effect of sex, age and type of diabetes in a nationwide analysis. (24th May 2021) Authors: Fauchier, L; Bisson, A; Fauchier, G; Bodin, A; Herbert, J; Angoulvant, D; Ducluzeau, PH; Lip, GYH Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LDL-cholesterol decrease by anti-PCSK9 monoclonal antibodies: systematic review, meta-analysis and meta-regression of randomized controlled trials. (25th November 2020) Authors: Ma, I; Angoulvant, D; Azzopardi, N; Ternant, D; Ivanes, F; Paintaud, G; Bejan-Angoulvant, T Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗